Clearside Biomedical, Inc.

NASDAQ:CLSD

1.3 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 0.090.236.3450.8591.0180.0040.330.2660.3840.34725.6873.0740.780.0340.0113.4320.3544.0971.9420.1410.0450.0450.030000.0550.1550.130.0050.0050.0050.0050.50500000
Cost of Revenue 0.0440.0280.020.1420.2130.0150.2040.0390.03803.8880000000000000000000000000000
Gross Profit 0.0460.2026.3250.7170.805-0.0110.1260.2270.3460.34721.7993.0740.780.0340.0113.4320.3544.0971.9420.1410.0450.0450.030000.0550.1550.130.0050.0050.0050.0050.50500000
Gross Profit Ratio 0.5110.8780.9970.8350.791-2.750.3820.8530.90110.8491111111111110001111111100000
Reseach & Development Expenses 4.5595.5876.2935.1344.9484.4515.0274.6375.434.5363.845.1474.065.494.4723.493.33.8111.3052.7280.65810.96717.48620.08317.34313.37913.93516.0511.4787.596.9713.6824.2134.5893.7982.3092.1472.5081.916
General & Administrative Expenses 3.0772.8242.9472.6373.1273.1583.1692.3532.7913.4573.142.8162.8162.8932.6492.3742.6113.1223.653.7815.0044.3844.1763.8733.5613.0742.4412.2982.292.6712.3911.6290.971.27300000
Selling & Marketing Expenses 000000000000000000000000000000000000000
SG&A 3.0772.8242.9472.6373.1273.1583.1692.3532.7913.4573.142.8162.8162.8932.6492.3742.6113.1223.653.7815.0044.3844.1763.8733.5613.0742.4412.2982.292.6712.3911.6290.971.2731.2181.0653.0231.2490.733
Other Expenses 1.917-1.4990.360.1420.4580.4920.4490.1940.0240.0020.0020.0020.0010.998-0.002-0.001-0.197-0.075-0.083-0.168-0.117-0.098-0.0060.0840.203-0.154-0.1720-0.1350-0.329-0.3390000000
Operating Expenses 7.6368.4119.247.9138.0757.6098.1966.998.2217.9936.987.9636.8768.3837.1215.8645.9116.9334.9556.5095.66215.35121.66223.95620.90416.45316.37618.34813.76810.2619.3625.3115.1835.8625.0163.3745.173.7572.649
Operating Income -7.59-8.209-2.915-7.054-7.27-7.605-8.07-6.724-7.837-7.64618.707-4.889-6.096-8.349-7.11-2.432-5.557-2.836-3.013-6.368-5.617-15.306-21.632-23.956-20.904-16.453-16.321-18.193-13.638-10.256-9.357-5.306-5.178-5.357-5.016-3.374-5.17-3.757-2.649
Operating Income Ratio -84.333-35.691-0.459-8.212-7.141-1,901.25-24.455-25.278-20.409-22.0350.728-1.59-7.815-245.559-646.364-0.709-15.698-0.692-1.551-45.163-124.822-340.133-721.067000-296.745-117.374-104.908-2,051.2-1,871.4-1,061.2-1,035.6-10.60800000
Total Other Income Expenses Net -0.004-3.554-1.917-2.2130.458-1.675-1.593-1.1030.0240.0020.0020.0020.0010.998-0.002-0.001-0.197-0.075-0.083-0.168-0.117-0.098-0.0060.0840.203-0.154-0.172-0.143-0.135-0.117-0.329-0.3390.076-0.092-0.154-0.101-0.0670-0.014
Income Before Tax -7.594-11.763-4.832-9.267-9.106-9.28-9.663-7.827-7.813-7.64418.709-4.887-6.095-7.351-7.112-2.433-5.754-2.911-3.096-6.536-5.734-15.404-21.638-23.872-20.701-16.607-16.493-18.336-13.773-10.373-9.686-5.645-5.102-5.449-5.17-3.475-5.237-3.757-2.663
Income Before Tax Ratio -84.378-51.143-0.762-10.788-8.945-2,320-29.282-29.425-20.346-22.0290.728-1.59-7.814-216.206-646.545-0.709-16.254-0.711-1.594-46.355-127.422-342.311-721.267000-299.873-118.297-105.946-2,074.6-1,937.2-1,129-1,020.4-10.7900000
Income Tax Expense 00-6.578-0.0162.7523.842-1.0741.103-0.024-0.0020000-0.044000-0.051-0.053-0.054-0.053-0.0480-0.0470-0.0470.143-0.0570.117-0.016-0.017-0.0760.010.0020.1010.0670.0040.004
Net Income -7.594-11.763-4.832-9.267-9.106-13.122-8.589-8.93-7.789-7.64218.709-4.887-6.095-7.351-7.112-2.433-5.754-2.911-3.096-6.536-5.734-15.404-21.638-23.872-20.701-16.607-16.493-18.336-13.773-10.373-9.686-5.645-5.102-5.449-5.17-3.475-5.237-3.757-2.663
Net Income Ratio -84.378-51.143-0.762-10.788-8.945-3,280.5-26.026-33.571-20.284-22.0230.728-1.59-7.814-216.206-646.545-0.709-16.254-0.711-1.594-46.355-127.422-342.311-721.267000-299.873-118.297-105.946-2,074.6-1,937.2-1,129-1,020.4-10.7900000
EPS -0.1-0.17-0.077-0.15-0.15-0.21-0.14-0.15-0.13-0.130.31-0.082-0.11-0.13-0.14-0.052-0.13-0.065-0.073-0.17-0.15-0.45-0.68-0.75-0.65-0.62-0.65-0.72-0.54-0.41-0.45-0.28-0.62-0.34-0.42-0.28-0.43-0.31-0.22
EPS Diluted -0.1-0.17-0.077-0.15-0.15-0.21-0.14-0.15-0.13-0.130.31-0.082-0.11-0.13-0.14-0.052-0.13-0.065-0.073-0.17-0.15-0.45-0.68-0.75-0.65-0.62-0.65-0.72-0.54-0.41-0.45-0.28-0.62-0.34-0.42-0.28-0.43-0.31-0.22
EBITDA -7.546-8.181-2.895-7.054-6.796-7.113-7.621-6.491-7.837-7.618.752-4.845-6.052-8.304-7.11-2.386-5.512-2.791-3.013-6.368-5.617-15.306-21.632-23.909-20.904-16.406-16.321-18.002-13.638-10.109-9.357-5.306-5.239-5.33-4.999-3.259-5.087-3.738-2.634
EBITDA Ratio -83.844-35.57-0.456-8.212-6.676-1,778.25-23.094-24.402-20.409-21.9020.73-1.576-7.759-244.235-646.364-0.695-15.571-0.681-1.551-45.163-124.822-340.133-721.067000-296.745-116.142-104.908-2,021.8-1,871.4-1,061.2-1,047.8-10.55400000